Literature DB >> 8271059

Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT.

H Hoshi1, T Ohnishi, S Jinnouchi, S Futami, S Nagamachi, T Kodama, K Watanabe, T Ueda, S Wakisaka.   

Abstract

UNLABELLED: We studied the usefulness of IMP SPECT with acetazolamide in 16 patients with moyamoya disease. Cerebral angiography was performed for all patients who were classified in three grades according to their angiographic stages.
METHODS: Techniques used included ring-type emission computed tomography with a minicomputer system. Patients received 111 MBq of 123I-IMP and SPECT images were obtained 20 min postinjection. Nine patients were studied using iodoamphetamine (IMP) SPECT with and without acetazolamide. IMP SPECT with acetazolamide was performed 20 min after each injection of 1 g of acetazolamide.
RESULTS: Low perfusion areas in the upper and lower frontal, parietal and temporal regions in grades 2 and 3 using IMP SPECT were observed. The mean cerebral-to-cerebellar activity ratios (C/C ratio) of six regions (upper and lower frontal, temporal, parietal occipital and basal ganglia) in grades 1, 2 and 3 were 0.96 to 1.06, 0.91 to 0.96 and 0.76 to 0.88, respectively.
CONCLUSION: Our results indicate that measurement of regional cerebral blood flow (rCBF) elucidates cerebral hemodynamic factors, including the reactivity of cerebral vessels which cannot be detected angiographically in patients with moyamoya disease, and that the acetazolamide test is useful for detecting cerebral blood flow reserve. The test can be used to detect disease progress prospectively.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8271059

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

1.  Localized 1H-MR spectroscopy in moyamoya disease before and after revascularization surgery.

Authors:  Soo Mee Lim; Hye-Young Choi; Jung Soo Suh; Jung Hee Lee; Keun Ho Lim; Dae Chul Suh; Ho Kyu Lee; Tae-Hwan Lim; Young Shin Ra
Journal:  Korean J Radiol       Date:  2003 Apr-Jun       Impact factor: 3.500

2.  Quantitative Assessment of Neovascularization after Indirect Bypass Surgery: Color-Coded Digital Subtraction Angiography in Pediatric Moyamoya Disease.

Authors:  H-H Cho; J-E Cheon; S-K Kim; Y H Choi; I-O Kim; W S Kim; S-M Lee; S K You; S-M Shin
Journal:  AJNR Am J Neuroradiol       Date:  2015-12-17       Impact factor: 3.825

3.  Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI.

Authors:  Robert Goetti; Ruth O'Gorman; Nadia Khan; Christian J Kellenberger; Ianina Scheer
Journal:  Neuroradiology       Date:  2013-02-13       Impact factor: 2.804

4.  Patient selection for revascularization procedures in adult Moyamoya disease based on dynamic perfusion computerized tomography with acetazolamide challenge (PCTA).

Authors:  Norberto Andaluz; Ondrej Choutka; Achala Vagal; Rhonda Strunk; Mario Zuccarello
Journal:  Neurosurg Rev       Date:  2010-02-06       Impact factor: 3.042

Review 5.  Neuroimaging of vascular reserve in patients with cerebrovascular diseases.

Authors:  Meher R Juttukonda; Manus J Donahue
Journal:  Neuroimage       Date:  2017-10-12       Impact factor: 6.556

6.  Neoangiogenesis in association with moyamoya syndrome shown by estimation of relative recirculation based on dynamic contrast-enhanced MR images.

Authors:  Andrea Kassner; Xiao-Ping Zhu; Kah-Lo Li; Alan Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

7.  Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease.

Authors:  Shigeyuki Sakamoto; Yoshihiro Kiura; Fumiyuki Yamasaki; Masaaki Shibukawa; Shinji Ohba; Prabin Shrestha; Kazuhiko Sugiyama; Kaoru Kurisu
Journal:  Neurosurg Rev       Date:  2007-10-03       Impact factor: 3.042

8.  Postoperative evaluation of moyamoya disease with perfusion-weighted MR imaging: initial experience.

Authors:  Seung-Koo Lee; Dong Ik Kim; Eun-Kee Jeong; Si-Yeon Kim; Sang Heum Kim; Yon Kwon In; Dong-Seok Kim; Joong-Uhn Choi
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

9.  Qualitative versus quantitative assessment of cerebrovascular reactivity to acetazolamide using iodine-123-N-isopropyl-p-iodoamphetamine SPECT in patients with unilateral major cerebral artery occlusive disease.

Authors:  Kuniaki Ogasawara; Taku Okuguchi; Masayuki Sasoh; Masakazu Kobayashi; Hirotsugu Yukawa; Kazunori Terasaki; Takashi Inoue; Akira Ogawa
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

10.  Cerebral-perfusion-based single-photon emission computed tomography (SPECT) staging using NeuroGam® in patients with moyamoya disease.

Authors:  Jai-Hyuck Han; Young Seok Park; Won Hyoung Lee; Sung-Soo Koong; Kyung-Soo Min; Mou-Seop Lee; Young-Gyu Kim; Dong-Ho Kim; Kyung-Sil Yi; Sang-Hoon Cha
Journal:  Childs Nerv Syst       Date:  2015-12-11       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.